In ₹ Crore except Per Share Latest Annual | VINEETLAB FY26 | BIOFILCHEM FY26 | MANGALAM FY26 | LASA FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | 36.00× | ◆ 21.05× | — | — | 21.05× +71% | |
| P/B | 1.52× | 2.72× | ◆ 0.54× | 0.69× | 0.69× +120% | |
| EV/EBITDA | 11.53× | 94.77× | ◆ -10.74× | -1.54× | -1.54× +851% | |
| Market Cap | ₹69.2 Cr | ₹58.6 Cr | ₹55.2 Cr | ₹34.2 Cr | ₹55.2 Cr +25% | |
| Growth | ||||||
| Revenue CAGR 3Y | -34.59% | ◆ -1.85% | — | -42.11% | -21.98% -57% | |
| Revenue CAGR 5Y | -24.58% | ◆ -4.50% | — | -34.11% | -19.30% -27% | |
| Net Income CAGR 3Y | 8.59% | ◆ 70.67% | — | — | 70.67% -88% | |
| Revenue YoY (latest Q) | 34.21% | ◆ 91.99% | -0.40% | -93.87% | -0.40% +8653% | |
| Net Income YoY (latest Q) | ◆ 111.58% | -95.47% | 44.64% | 83.05% | 44.64% +150% | |
| Profitability | ||||||
| EBITDA Margin | ◆ 14.27% | 2.29% | -6.42% | -112.98% | -6.42% +322% | |
| Net Income Margin | 2.70% | ◆ 9.81% | -19.13% | -135.60% | -19.13% +114% | |
| Return on Common Equity | 3.52% | ◆ 12.92% | -43.08% | -68.70% | -43.08% +108% | |
| Return on Capital Employed | ◆ 10.55% | 1.70% | -27.98% | -69.54% | -27.98% +138% | |
| Return on Assets | 1.29% | ◆ 6.50% | -14.10% | -51.44% | -14.10% +109% | |
| Credit & Quality | ||||||
| Total Debt/Equity | 0.99× | ◆ 0.14× | 1.02× | 0.20× | 0.20× +395% | |
| Interest Coverage | 1.24× | ◆ 37.37× | -2.04× | -89.13× | -2.04× +161% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹59.4 Cr | ₹28.4 Cr | ₹232 Cr | ₹25.1 Cr | ₹28.4 Cr +109% | |
| Net Income | ₹1.6 Cr | ₹2.8 Cr | −₹44.4 Cr | −₹34.1 Cr | −₹34.1 Cr +105% | |
| Total Assets | ₹125 Cr | ₹42.8 Cr | ₹315 Cr | ₹66.3 Cr | ₹66.3 Cr +88% | |
| EPS | ₹1 | ₹1.71 | ₹-28.05 | ₹-6.8 | ₹-6.8 +115% | |
| Book Value per Share | ₹23.74 | ₹13.25 | ₹65.11 | ₹9.9 | ₹13.25 +79% | |